Evidence map›Paper›PMID 36790548›Full record

ArticleJournal of neurology2023

Impact of GBA variants on longitudinal freezing of gait progression in early Parkinson's disease.

Nannan Yang, Shushan Sang, Tao Peng, Wentao Hu, Jingtao Wang, Rong Bai, Hong Lu

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Longitudinal faster anxiety progression ofFrontiers in neuroscience · 2024
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Nannan YangDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. xyynn1990@163.com.ORCID http://orcid.org/0000-0002-3003-9702
Shushan SangDepartment of Otolaryngology Head and Neck Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Tao PengDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Wentao HuDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Jingtao WangDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Rong BaiDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Hong LuDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. zzu_luhong@163.com.
First Affiliated Hospital of Zhengzhou University · CN

Funding

China Postdoctoral Science Foundation funded project 2021M702945National Natural Science Foundation of China 81971175National Natural Science Foundation of China 82101940
6 · The paper itself

Abstract

backgroundFreezing of gait (FOG) is a common disabling gait disturbance among patients with Parkinson's disease (PD), but the influence of genetic variants on the incidence of FOG has been poorly studied to date.

objectivesWe aimed to evaluate the association of GBA variants with the risk of FOG development in a large early PD cohort.

methodsThis study included 371 early PD patients from the Parkinson's Progression Markers Initiative (PPMI) who were divided into a GBA variant carrier group (GBA-PD group, n = 44) and an idiopathic PD group without GBA variants (iPD group, n = 327). They were followed up for up to 5 years to examine the progression of FOG. The cumulative incidence of FOG and risk factors for FOG were assessed using Kaplan‒Meier and Cox regression analyses.

resultsAt baseline, the GBA-PD group had lower CSF β-amyloid 1-42 (Aβ

conclusionGBA variants are novel genetic risk factors for future FOG development in early PD patients. This association seemed to be mediated by both Aβ-dependent pathways and Aβ-independent pathways.

Indexed as

Gait Disorders, NeurologicParkinson DiseaseGaitGlucosylceramidaseHumansIncidenceRisk FactorsGBA protein, humanGlucosylceramidaseFreezing of gaitGBA variantsParkinson’s diseaseβ-Amyloid

Identifiers

PMID36790548
OpenAlexW4320856427

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.